|
|
| (129 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| | + | |
| | | | |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| | | | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32143990|t=ä. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |pdf=|usr=}}
| + | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=32113704|t=2020. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak |pdf=|usr=}}
| + | |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Structure of covid19]]''' | + | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=32361692|t=2020. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure |pdf=|usr=}}
| + | |
| − | {{tp|p=32306836|t=2020. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment |pdf=|usr=}}
| + | |
| | | | |
| − | *'''[[Target binding and uptake]]''' | + | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=32344526|t=2020. COVID-19 and RAS: Unravelling an Unclear Relationship |pdf=|usr=}}
| + | |
| − | {{tp|p=32274964|t=2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Cytopathic effects]]''' | + | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| | | | |
| − | *'''[[Secretion and shedding]]''' | + | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| − | *'''[[Innate sensing]]'''
| |
| | | | |
| − | *'''[[Immunology]]'''
| |
| − | {{tp|p=32360285|t=ä. Type I IFN immunoprofiling in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=32344056|t=ä. Eosinophil Responses During COVID-19 Infections and Coronavirus Vaccination |pdf=|usr=}}
| |
| − | {{tp|p=32333914|t=ä. A possible role for B cells in COVID-19?: Lesson from patients with Agammaglobulinemia |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | + | *'''[[Structure of covid19]]''' |
| − | {{tp|p=32334118|t=ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32360286|t=2020. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32311489|t=ä. Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | + | *'''[[Target binding and uptake]]''' |
| | + | *'''[[Cytopathic effects]]''' |
| | + | *'''[[Secretion and shedding]]''' |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Early symptoms]]''' | + | *'''[[Innate sensing]]''' |
| | | | |
| − | *'''[[Systemic disease, any manifestations]]''' | + | *'''[[Immunology]]''' |
| | | | |
| − | *'''[[Co-Infection]]''' | + | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| | | | |
| − | *'''[[ARDS]]'''
| |
| | | | |
| − | *'''[[Pulmonary embolism, coagulation]]'''
| |
| − | {{tp|p=32311448|t=ä. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Hematology]]''' | + | *'''[[Pathobiology]]''' |
| | | | |
| − | *'''[[Microvascular]]'''
| |
| | | | |
| − | *'''[[Heart]]''' | + | *'''[[Disease Models]]''' |
| | | | |
| − | *'''[[Neurology, ophthalmology, orl]]'''
| |
| − | {{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
| |
| − | {{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Similar diseases and pathomechanisms]]''' |
| | | | |
| − | *'''[[Dermatology]]'''
| |
| | | | |
| − | *'''[[Gastroenterology, hepatology]]'''
| |
| | | | |
| − | *'''[[Kidney, urology]]'''
| |
| | | | |
| − | ----
| + | *'''[[Early symptoms]]''' |
| | | | |
| | + | *'''[[Systemic disease, any manifestations]]''' |
| | | | |
| − | *'''[[Pathobiology]]''' | + | *'''[[Co-Infection]]''' |
| − | {{tp|p=32094336|t=2020. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa |pdf=|usr=}}
| + | |
| − | {{tp|p=32283245|t=ä. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated |pdf=|usr=}}
| + | |
| − | {{tp|p=32282428|t=ä. What s Old is New! Similarities Between SARS-CoV-2 and HIV |pdf=|usr=}}
| + | |
| − | {{tp|p=32303424|t=ä. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32315733|t=ä. Elevated troponin in patients with Coronavirus Disease 2019 (COVID-19): possible mechanisms |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Disease Models]]''' | + | *'''[[Pulmonary embolism, coagulation]]''' |
| | | | |
| − | *'''[[Similar diseases and pathomechanisms]]'''
| |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Laboratory)]]'''
| |
| − | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| |
| − | {{tp|p=32286019|t=2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[Diagnosis (Lung CT, Sonography)]]''' | + | *'''[[Hematology]]''' |
| − | {{tp|p=32283052|t=ä. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis |pdf=|usr=}}
| + | |
| − | {{tp|p=32236303|t=2020. COVID-19 pneumonia: what is the role of imaging in diagnosis?|pdf=|usr=}}
| + | |
| − | {{tp|p=32321009|t=2020. COVID-19 pneumonia and the reversed halo sign |pdf=|usr=}}
| + | |
| − | {{tp|p=32294718|t=2020. Presentation of pulmonary infection on CT in COVID-19: initial experience in Brazil |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Diagnosis (other modalities)]]''' | + | *'''[[Heart]]''' |
| − | {{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Respiration mgmt]]'''
| |
| − | {{tp|p=32251794|t=2020. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment of severe COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32303885|t=ä. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series |pdf=|usr=}}
| |
| − | {{tp|p=32337192|t=2020. COVID-19 Tragic Pandemic: Concerns over Unintentional ?Directed Accelerated Evolution? of Novel Coronavirus (SARS-CoV-2) and Introducing a Modified Treatment Method for ARDS |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Neurology, ophthalmology, orl]]''' |
| | | | |
| | | | |
| − | *'''[[Clinical guidelines and advice]]'''
| |
| − | {{tp|p=32361701|t=2020. COVID-19 Rapid Guideline in Kidney Transplant Recipients |pdf=|usr=}}
| |
| − | {{tp|p=32378816|t=2020. Clinical Insights and Management Recommendations for COVID-19 Patients Hospitalized in Internal Medicine Departments: Recommendations by the Corona Department Heads in Israel |pdf=|usr=}}
| |
| − | {{tp|p=32278795|t=ä. Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Dermatology]]''' |
| | | | |
| | | | |
| − | *'''[[Risk and special populations]]'''
| |
| − | {{tp|p=32330545|t=ä. African American COVID-19 Mortality: A Sentinel Event |pdf=|usr=}}
| |
| − | {{tp|p=32305401|t=ä. Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System |pdf=|usr=}}
| |
| − | {{tp|p=32154911|t=2020. COVID?19 Presents High Risk to Older Persons |pdf=|usr=}}
| |
| − | {{tp|p=32233755|t=2020. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32233753|t=2020. Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?|pdf=|usr=}}
| |
| − | {{tp|p=32347144|t=2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors |pdf=|usr=}}
| |
| − | {{tp|p=32253068|t=2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Gastroenterology, hepatology]]''' |
| | + | |
| | + | *'''[[Kidney, urology]]''' |
| | | | |
| | *'''[[The morbid survivor]]''' | | *'''[[The morbid survivor]]''' |
| − | {{tp|p=32334770|t=2020. The Need to Include Assisted Living in Responding to the COVID-19 Pandemic |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Case reports]]''' | + | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32269194|t=2020. Pneumonia Without Respiratory Symptoms |pdf=|usr=}}
| + | |
| − | {{tp|p=32361703|t=2020. Newly Diagnosed Glomerulonephritis During COVID-19 Infection Undergoing Immunosuppression Therapy, a Case Report |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| − | *'''[[Case series]]''' | + | *'''[[Case reports]]''' |
| − | {{tp|p=32378815|t=2020. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Registries]]'''
| |
| − | {{tp|p=32305438|t=ä. The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19 |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Trials]]'''
| |
| − | {{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Case series]]''' |
| | | | |
| − | *'''[[Candidate Compounds Covid19]]'''
| |
| − | {{tp|p=32330546|t=ä. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin |pdf=|usr=}}
| |
| − | {{tp|p=32283123|t=ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment |pdf=|usr=}}
| |
| − | {{tp|p=32336674|t=ä. COVID-19 Emergency Responders in FDA?s Center for Drug Evaluation and Research |pdf=|usr=}}
| |
| − | {{tp|p=32361744|t=ä. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease |pdf=|usr=}}
| |
| − | {{tp|p=32196083|t=ä. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression |pdf=|usr=}}
| |
| − | {{tp|p=32317220|t=ä. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32291137|t=ä. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?|pdf=|usr=}}
| |
| − | {{tp|p=32284326|t=2020. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency |pdf=|usr=}}
| |
| − | {{tp|p=32094225|t=2020. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32295479|t=2020. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study |pdf=|usr=}}
| |
| − | {{tp|p=32306862|t=2020. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes |pdf=|usr=}}
| |
| − | {{tp|p=32266873|t=2020. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2?-O-ribose methyltransferase |pdf=|usr=}}
| |
| − | {{tp|p=32238078|t=2020. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Registries]]''' |
| | | | |
| | | | |
| | + | *'''[[Trials]]''' |
| | | | |
| | + | *'''[[Candidate Compounds Covid19]]''' |
| | | | |
| | | | |
| − | | + | *'''[[Other routes of infection]]''' |
| − | ----
| + | |
| | | | |
| | | | |
| | *'''[[Biophysics of aerosols]]''' | | *'''[[Biophysics of aerosols]]''' |
| − | {{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Other routes of infection]]'''
| |
| − | {{tp|p=32335340|t=ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health |pdf=|usr=}}
| |
| − | {{tp|p=32278800|t=ä. Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?|pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Passive protective equipment]]''' |
| | | | |
| − | *'''[[Remission, recurrence and persistence]]'''
| |
| − | {{tp|p=32200109|t=2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge |pdf=|usr=}}
| |
| − | {{tp|p=32251796|t=ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?|pdf=|usr=}}
| |
| − | {{tp|p=32147538|t=2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | *'''[[Passive protective equipment]]'''
| |
| − | {{tp|p=32278727|t=ä. Ethical Rationing of Personal Protective Equipment to Minimize Moral Residue During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32240303|t=ä. Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32353399|t=ä. Institution of a Novel Process for N95 Respirator Disinfection with Vaporized Hydrogen Peroxide in the setting of the COVID-19 Pandemic at a Large Academic Medical Center |pdf=|usr=}}
| |
| − | {{tp|p=32370924|t=ä. Personal Protective Equipment: Current Best Practices for Orthopaedic Teams |pdf=|usr=}}
| |
| − | {{tp|p=32354536|t=ä. Helmet Modification to PPE with 3D Printing During the COVID-19 Pandemic at Duke University Medical Center: A Novel Technique |pdf=|usr=}}
| |
| | | | |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32278716|t=ä. The Restructuring of Structural Heart Disease Practice During The Covid-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32330544|t=ä. Management of Acute Myocardial Infarction During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32305402|t=ä. Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective |pdf=|usr=}}
| |
| − | {{tp|p=32208140|t=ä. The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management and Infection Control in a Radiology Department |pdf=|usr=}}
| |
| − | {{tp|p=32208138|t=ä. Novel Screening and Triage Strategy in Iran During Deadly Coronavirus Disease 2019 (COVID-19) Epidemic: Value of Humanitarian Teleconsultation Service |pdf=|usr=}}
| |
| − | {{tp|p=32304643|t=ä. Coronavirus Outbreak: Is Radiology Ready? Mass Casualty Incident Planning |pdf=|usr=}}
| |
| − | {{tp|p=32298643|t=ä. Operational Strategies to Prevent COVID-19 spread in Radiology: Experience from a Singapore Radiology Department after SARS |pdf=|usr=}}
| |
| − | {{tp|p=32360525|t=ä. COVID-19 and Your Radiology Practice: Case Triage, Staffing Strategies, and Addressing Revenue Concerns |pdf=|usr=}}
| |
| − | {{tp|p=32335184|t=ä. Coronavirus Disease 2019 (COVID-19) and Radiology Education?Strategies for Survival |pdf=|usr=}}
| |
| − | {{tp|p=32360528|t=ä. Touch Me Not: Physical Distancing in Radiology during COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32348740|t=ä. Italian Radiology?s Response to the COVID-19 Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32315599|t=ä. Academic Radiology Departmental Operational Strategy Related to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7146721|t=ä. Ventilation-perfusion Scans During the Coronavirus (COVID 19) Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32092296|t=2020. Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know |pdf=|usr=}}
| |
| − | {{tp|p=32240770|t=ä. Maximizing the Calm Before the Storm: Tiered Surgical Response Plan for Novel Coronavirus (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32229297|t=ä. Lessons Learned During the COVID-19 Virus Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32278730|t=ä. Ongoing Lessons During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32278729|t=ä. Surgical Response to COVID-19 Pandemic: A Singapore Perspective |pdf=|usr=}}
| |
| − | {{tp|p=32278728|t=ä. Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32278725|t=ä. Medically Necessary, Time-Sensitive Procedures: Scoring System to Ethically and Efficiently Manage Resource Scarcity and Provider Risk During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32278726|t=ä. Rapid Response of an Academic Surgical Department to the COVID-19 Pandemic: Implications for Patients, Surgeons, and the Community |pdf=|usr=}}
| |
| − | {{tp|p=32360960|t=ä. Implementation Guide for Rapid Integration of an Outpatient Telemedicine Program during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32251848|t=ä. Residency and Fellowship Program Accreditation: Effects of the Novel Coronavirus (COVID-19) Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32289376|t=ä. Collaborative Multidisciplinary Incident Command at Seattle Children?s Hospital for Rapid Preparatory Pediatric Surgery Countermeasures to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32283270|t=ä. Surgeons, Ethics, and COVID-19: Early Lessons Learned |pdf=|usr=}}
| |
| − | {{tp|p=32283269|t=ä. Rural Healthcare Center Preparation and Readiness Response to Threat of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32276721|t=2020. Ethical practice during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32283268|t=ä. Novel Approach to Reduce Transmission of COVID-19 During Tracheostomy |pdf=|usr=}}
| |
| − | {{tp|p=32232432|t=ä. Balancing Health Privacy, Health Information Exchange and Research in the Context of the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32208481|t=ä. Rapid Response to COVID-19: Health Informatics Support for Outbreak Management in an Academic Health System |pdf=|usr=}}
| |
| − | {{tp|p=32348469|t=ä. Laboratory information system requirements to manage the COVID-19 pandemic: a report from the Belgian national reference testing center |pdf=|usr=}}
| |
| − | {{tp|p=32267928|t=ä. Rapid Design and Implementation of an Integrated Patient Self-Triage and Self-Scheduling Tool for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32333757|t=ä. When Past Isn?t a Prologue: Adapting Informatics Practice During a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32324855|t=ä. COVID-19 transforms health care through telemedicine: evidence from the field |pdf=|usr=}}
| |
| − | {{tp|p=32311036|t=ä. How hospitals in mainland China responded to the outbreak of COVID-19 using IT-enabled services: an analysis of hospital news webpages |pdf=|usr=}}
| |
| − | {{tp|p=32311034|t=ä. Telehealth Transformation: COVID-19 and the rise of Virtual Care |pdf=|usr=}}
| |
| − | {{tp|p=32302395|t=ä. Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results |pdf=|usr=}}
| |
| − | {{tp|p=32282922|t=ä. Use of self-administered surveys through QR code and same center telemedicine in a walk-in clinic in the era of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32336673|t=ä. Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32305209|t=ä. Preparing pharmacy for the surge of patients with COVID-19: Lessons from China |pdf=|usr=}}
| |
| − | {{tp|p=32284276|t=ä. The COVID-19 pandemic: implications for the cytology laboratory |pdf=|usr=}}
| |
| − | {{tp|p=32370923|t=ä. Disruption of Arthroplasty Practice in an Orthopedic Center in Northern Italy During the Coronavirus Disease 2019 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32354537|t=ä. American Association of Hip and Knee Surgeons Advocacy Efforts in Response to the SARS-CoV-2 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32354535|t=ä. The Rapid Response to the COVID-19 Pandemic by the Arthroplasty Divisions at Two Academic Referral Centers |pdf=|usr=}}
| |
| − | {{tp|p=32345566|t=ä. Economic Recovery After the COVID-19 Pandemic: Resuming Elective Orthopedic Surgery and Total Joint Arthroplasty |pdf=|usr=}}
| |
| − | {{tp|p=32345564|t=ä. The Past, Present, and Future of Orthopaedic Education: Lessons Learned from the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32340829|t=ä. Educating Surgeons to Educate Patients About the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32282419|t=ä. A Review of State Guidelines for Elective Orthopaedic Procedures During the COVID-19 Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32205711|t=ä. Bronchoscopy in the Age of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32342200|t=ä. A quick evaluation method of nosocomial infection risk for cancer hospitals during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32195687|t=ä. American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients With Suspected or Confirmed COVID-19 Infection |pdf=|usr=}}
| |
| − | {{tp|p=32335850|t=ä. Addressing the needs of cancer survivors during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32315732|t=ä. Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America |pdf=|usr=}}
| |
| − | {{tp|p=32178954|t=2020. Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − | {{tp|p=32259628|t=ä. Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist |pdf=|usr=}}
| + | |
| − | {{tp|p=32208139|t=ä. Coronavirus Disease 2019 (COVID-19) and Beyond: Micropractices for Burnout Prevention and Emotional Wellness |pdf=|usr=}}
| + | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Socio-psychiatric aspects of the status hygienicus]]'''
| |
| − | {{tp|p=32360185|t=ä. Exercise and Fitness in the age of social distancing during the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32078967|t=2020. Coronaphobia: Fear and the 2019-nCoV outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32333185|t=ä. Social and behavioral health responses to COVID-19: lessons learned from four decades of an HIV pandemic |pdf=|usr=}}
| |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| − | {{tp|p=32283124|t=ä. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| | + | |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
| |
| − | {{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
| |
| − | {{tp|p=32292707|t=ä. Death and contagious infectious diseases: Impact of the COVID-19 virus on stock market returns |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 290: |
Zeile 145: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=32212099|t=ä. COVID-19 may transmit through aerosol |pdf=|usr=}}
| |
| | | | |
| | *'''[[Origin of Covid19]]''' | | *'''[[Origin of Covid19]]''' |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32225178|t=2020. The Impact of COVID-19 on Italy: A Lesson for the Future |pdf=|usr=}}
| |
| − | {{tp|p=32218558|t=2020. Preparedness and Lessons Learned from the Novel Coronavirus Disease |pdf=|usr=}}
| |
| − | {{tp|p=32271914|t=ä. The hearth of mathematical and statistical modelling during the Coronavirus pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32123989|t=ä. The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges |pdf=|usr=}}
| |
| − | {{tp|p=32219674|t=ä. Application of personal-oriented digital technology in preventing transmission of COVID-19, China |pdf=|usr=}}
| |
| − | {{tp|p=32334771|t=ä. COVID-19 in Italy: Ageism and Decision-Making in a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32333753|t=ä. An Interactive Online Dashboard for Tracking COVID-19 in U S Counties, Cities, and States in Real Time |pdf=|usr=}}
| |
| − | {{tp|p=32311047|t=ä. Following Data as it Crosses Borders During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32282412|t=ä. Preparing to Perform Trauma and Orthopaedic Surgery on Patients with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7152868|t=ä. Adapting palliative radiation therapy for bone metastases during the Covid-19 pandemic: GEMO position paper |pdf=|usr=}}
| |
| | | | |
| − | *'''[[Failure of politics and public health guidance]]''' | + | |
| | + | |
| | + | |
| | + | |
| | + | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | + | *'''[[Failure of politics and public health guidance]]''' |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
| + | |
| − | *[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
| + | |
| | | | |
| | | | |
| | *'''[[Lost people]]''' | | *'''[[Lost people]]''' |
| − | {{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32271208|t=ä. Survey of COVID-19 Disease Among Orthopaedic Surgeons in Wuhan, People?s Republic of China |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Lost civilization]]''' | | *'''[[Lost civilization]]''' |
| | + | |
| | ---- | | ---- |
| | | | |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − |
| |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32343813|t=ä. Impact of the digital divide in the age of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32313877|t=ä. COVID-19 Epidemic and Enhancing China?s National Biosecurity System |pdf=|usr=}}
| |
| − | {{tp|p=32282413|t=ä. What?s Important: What Is Our Role in the COVID-19 Pandemic?|pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Research tools]]''' | | *'''[[Research tools]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | + | |
| | + | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| − | *[lifechemicals.com antiviral candidate drugs]
| |
| − | *[biomol.com assays cytokines general spectrum]
| |
| | | | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | + | *'''[[on-topic personal thoughts]]''' |
